Bulletin
Investor Alert

Corbus Pharmaceuticals Holdings Inc.

NAS: CRBP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 27, 2021, 7:59 p.m.

/zigman2/quotes/201549545/composite

$

2.00

Change

+0.05 +2.56%

Volume

Volume 751,999

Quotes are delayed by 20 min

/zigman2/quotes/201549545/composite

Today's close

$ 1.97

$ 1.95

Change

-0.02 -1.02%

Day low

Day high

$1.81

$2.17

Open

52 week low

52 week high

$0.91

$9.78

Open

Insider Actions for Corbus Pharmaceuticals Holdings Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/21/2020 Sean F. Moran
Chief Financial Officer
87,500   Disposition at $1.75 per share. 153,125
12/21/2020 Sean F. Moran
Chief Financial Officer
87,500   Derivative/Non-derivative trans. at $1.4 per share. 122,500
12/18/2020 Sean F. Moran
Chief Financial Officer
53,610   Disposition at $1.4 per share. 75,054
12/18/2020 Sean F. Moran
Chief Financial Officer
53,610   Derivative/Non-derivative trans. at $1 per share. 53,610
12/16/2020 Sean F. Moran
Chief Financial Officer
36,923   Disposition at $1.32 per share. 48,738
12/16/2020 Sean F. Moran
Chief Financial Officer
36,923   Derivative/Non-derivative trans. at $0.17 per share. 6,276
11/11/2020 Yuval Cohen
Chief Executive Officer; Director
4,240   Acquisition at $1.21 per share. 5,130
03/17/2020 Barbara White
Chief Medical Officer
15,606   Acquisition at $3.63 per share. 56,649
03/17/2020 Yuval Cohen
Chief Executive Officer; Director
4,300   Acquisition at $3.49 per share. 15,007
03/17/2020 Robert Discordia
Chief Operating Officer
2,840   Acquisition at $3.54 per share. 10,053
03/17/2020 Craig Millian
Chief Commercial Officer
2,000   Acquisition at $4.25 per share. 8,500
11/12/2019 Barbara White
Chief Medical Officer
3,424   Acquisition at $4.38 per share. 14,997
11/12/2019 Yuval Cohen
Chief Executive Officer; Director
1,430   Acquisition at $4.26 per share. 6,091
11/11/2019 Robert Discordia
Chief Operating Officer
2,500   Acquisition at $4.62 per share. 11,550
11/11/2019 Craig Millian
Chief Commercial Officer
1,000   Acquisition at $4.38 per share. 4,380
08/15/2019 Craig Millian
Chief Commercial Officer
1,500   Acquisition at $5.48 per share. 8,220
08/12/2019 Barbara White
Chief Medical Officer
1,639   Acquisition at $6.1 per share. 9,997
08/12/2019 Yuval Cohen
Chief Executive Officer; Director
1,175   Acquisition at $6.06 per share. 7,120
08/12/2019 Robert Discordia
Chief Operating Officer
15,000   Acquisition at $5.86 per share. 87,900
08/12/2019 Craig Millian
Chief Commercial Officer
1,500   Acquisition at $6 per share. 9,000
05/17/2019 Barbara White
Chief Medical Officer
1,389   Acquisition at $7.2 per share. 10,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
4 Purchases
3 Sales
182,273
178,033
Last 6 months
4 Purchases
3 Sales
182,273
178,033
Last 12 months
8 Purchases
3 Sales
207,019
178,033

Officers and Executives

Dr. Yuval Cohen
Chief Executive Officer & Director
Mr. Sean F. Moran
Chief Financial & Accounting Officer
Dr. Barbara White
Chief Medical Officer
Dr. Sergei Atamas
Executive Director-Research
Mr. Craig Millian
Chief Commercial Officer
Mr. Ross Lobell
Vice President-Regulatory Affairs
Mr. Alan F. Holmer
Chairman
Dr. Peter Salzmann
Independent Director
Mr. Avery W. Catlin
Independent Director
Dr. John Kenneth Jenkins
Independent Director
Ms. Rachelle Jacques
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.